![(4-hydroxy-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-3-yl)methyl benz oate structure, CAS 6022-96-4](/structures/210000/190856_2_6022_96_4.png)
CAS Number6022-96-4
Synonyms(4-hydroxy-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-3-yl)methylbenzoate; 5-O-benzoyl-1,2-O-isopropylidene-D-xylofuranose; α-D-Xylofuranose, 1,2-O-(1-methylethylidene)-, 5-benzoate; 5-O-Benzoyl-1,2-O-isopropylidene-α-D-xylofuranose; [(3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate; [(3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methylbenzoat
Molecular FormulaC15H18O6
Molecular Weight294.30
Density1.3±0.1 g/cm3
Boiling Point432.0±40.0 °C at 760 mmHg
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 6022-96-4 |
| Catalog No. | 2A-2189446 |
| Chinese Name | 1,2-O-(异丙亚基)-ALPHA-D-呋喃木糖 5-苯甲酸酯 |
| Synonyms | (4-hydroxy-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-3-yl)methylbenzoate; 5-O-benzoyl-1,2-O-isopropylidene-D-xylofuranose; α-D-Xylofuranose, 1,2-O-(1-methylethylidene)-, 5-benzoate; 5-O-Benzoyl-1,2-O-isopropylidene-α-D-xylofuranose; [(3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methyl benzoate; [(3aR,5R,6S,6aR)-6-Hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methylbenzoat |
| Molecular Formula | C15H18O6 |
| Molecular Weight | 294.30 |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 432.0±40.0 °C at 760 mmHg |
| Application | 5-O-benzoyl-1,2-di-O-isopropylidene-α-D-ylfuranosine is a purine nucleoside analog. Purine nucleoside analogues have broad antitumor activity and target indolent lymphoid malignancies. The anti-cancer |
| PubChem ID | 16934656 |
| SMILES | CC1(C)OC2OC(COC(=O)c3ccccc3)C(O)C2O1 |
| InChI | InChI=1S/C15H18O6/c1-15(2)20-12-11(16)10(19-14(12)21-15)8-18-13(17)9-6-4-3-5-7-9/h3-7,10-12,14,16H,8H2,1-2H3 |
| InChI Key | WKRBIHIDJVMVGS-UHFFFAOYSA-N |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-4-CARBOXYPHENYLGLYCINE | 134052-73-6 | 2A-1189260 |
| (2R,3S,4S,5R)-5-Hydroxy-2,3,4-tris(phenylMethoxy)-5-[(phenylMethoxy)Methyl]-cyclohexanone | 911439-19-5 | 2A-1189284 |
| 1-PROPANAMINE, 3-[3-(1-PIPERIDINYLMETHYL)PHENOXY]-, DIHYDROCHLORIDE | 87766-25-4 | 2A-2189311 |
| Quinoxaline, 2-(1-methyl-1H-pyrazol-4-yl)-7-nitro- | 1346245-03-1 | 2A-2189356 |
| (R)-1-phenylethan-1-aminium (2S, 3S)-3-(4-(phenylethynyl)phenyl)-2-(2,2,2-trifluoroacetamido)pent-4-enoate (Compound-5) | 2449218-80-6 | 2A-1189340 |
| (2R,4S)-4-bromotetrahydrofuran-2-carboxylic acid | 161855-14-7 | 2A-1189465 |
| Benzenesulfonyl chloride, 5-amino-2-methyl- | 98280-38-7 | 2A-1189469 |
| 2-FLUORO-5-NITROBENZENESULFONYL CHLORIDE | 713-21-3 | 2A-1189477 |
| 3-amino-4-fluorobenzenesulfonyl chloride | 612548-20-6 | 2A-1189481 |
| (4-hydroxy-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-3-yl)methyl benz oate | 6612-91-5 | 2A-2189484 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS